Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

Define Study Investigators; Raymond Hupperts

doi:10.1056/NEJMoa1114287

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

Define Study Investigators, Raymond Hupperts

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1098-1107
Journal	New England Journal of Medicine
Volume	367
Issue number	12
DOIs	https://doi.org/10.1056/NEJMoa1114287
Publication status	Published - 20 Sep 2012

Access to Document

10.1056/NEJMoa1114287

Cite this

Define Study Investigators, & Hupperts, R. (2012). Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis. New England Journal of Medicine, 367(12), 1098-1107. https://doi.org/10.1056/NEJMoa1114287

@article{1c9ffec756e24c8992303d1c4aee3697,

title = "Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis",

author = "Ralf Gold and Ludwig Kappos and Arnold, {Douglas L.} and Amit Bar-Or and Gavin Giovannoni and Selmaj, {Krzysztof W.} and Carlo Tornatore and Sweetser, {Marianne T.} and Minhua Yang and Sheikh, {Sarah I.} and {Define Study Investigators} and Raymond Hupperts and Dawson, {Katherine T.}",

year = "2012",

month = sep,

day = "20",

doi = "10.1056/NEJMoa1114287",

language = "English",

volume = "367",

pages = "1098--1107",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "MASSACHUSETTS MEDICAL SOCIETY",

number = "12",

}

TY - JOUR

T1 - Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

AU - Gold, Ralf

AU - Kappos, Ludwig

AU - Arnold, Douglas L.

AU - Bar-Or, Amit

AU - Giovannoni, Gavin

AU - Selmaj, Krzysztof W.

AU - Tornatore, Carlo

AU - Sweetser, Marianne T.

AU - Yang, Minhua

AU - Sheikh, Sarah I.

AU - Define Study Investigators

AU - Hupperts, Raymond

AU - Dawson, Katherine T.

PY - 2012/9/20

Y1 - 2012/9/20

U2 - 10.1056/NEJMoa1114287

DO - 10.1056/NEJMoa1114287

M3 - Article

VL - 367

SP - 1098

EP - 1107

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 12

ER -